Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Decoy Therapeutics Inc (DCOY) had Free Cash Flow of $-5.58M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.23M |
|
$-2.37M |
|
-- |
|
$0.23M |
|
$2.63M |
|
$-2.40M |
|
$0.03M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.40M |
|
$-2.39M |
|
0.53M |
|
0.53M |
|
$-4.46 |
|
$-4.46 |
|
| Balance Sheet Financials | |
$8.57M |
|
$0.40M |
|
$0.43M |
|
$9.00M |
|
$4.68M |
|
-- |
|
-- |
|
$4.68M |
|
$4.32M |
|
$4.32M |
|
$4.32M |
|
0.53M |
|
| Cash Flow Statement Financials | |
$-5.54M |
|
$-0.04M |
|
$3.16M |
|
$10.71M |
|
$8.29M |
|
$-2.42M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1055.84% |
|
-1055.84% |
|
-- |
|
-1042.84% |
|
-1042.84% |
|
|
Free Cash Flow |
$-5.58M |
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-54.94% |
|
-54.94% |
|
-26.37% |
|
-54.94% |
|
$8.12 |
|
$-10.50 |
|
$-10.42 |
|